Net Loss per Common Share

6 Months Ended

Jun. 30, 2026

12. Net Loss per Common Share

The following potentially dilutive securities have been excluded from the calculation of diluted net loss per common share due to their anti-dilutive effect:


	June 30,
	2026		2025
Stock options outstanding		15,801,800		12,717,406
Non-vested and unsettled restricted stock units		393,248		1,942,478
Shares reserved for future issuance		4,871,763		4,987,940
Apexigen replacement warrants		1,003,191		1,003,191
Employee stock purchase plan		715,570		653,777
Total		22,785,572		21,304,792